TRIB2 and central nervous system cancer: The IHC results showed that TRIB2 was predominantly expressed in the nucleus, and MAP3K1 was enriched in the cytoplasm and cytomembrane of glioma cells, while no significant staining was observed in the nontumor tissues (Figure 5).